ArticleMolecular neurobiology2025
G Proteins-Associated Dose-Dependent Effects of Oxytocin on Oxytocin Neuronal Activity and Astrocytic Plasticity of the Supraoptic Nucleus.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?Molecular neurobiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Dose-dependent neuromodulation has been well established; however, the molecular mechanisms underlying astrocytic involvement in this process remain largely unexplored. Using the autoregulation of supraoptic oxytocin (OT) neurons (OTNs) as a model, we investigated the role of distinct astrocytic G proteins and their targets in the dose-dependent effects of OT on OTN activity. The results showed that OT in a low concentration (10 pmol/L, L-OT) excited OTN activity, whereas a high concentration (1 nmol/L, H-OT) inhibited it in brain slices. These effects were abolished upon disruption of astrocytic plasticity using L-aminoadipic acid, a gliotoxin. In primary astrocyte cultures, L-OT slightly reduced the current through astrocyte-specific inwardly rectifying K⁺ channel 4.1 (Kir4.1) while H-OT strongly enhanced it. Selectively blocking Kir4.1 with BaCl₂ (100 µmol/L) did not affect the basal activity but blocked the excitatory effect of L-OT in brain slices. In cultured astrocytes, L-OT mobilized Gαq subunit expression, increased glial fibrillary acidic protein (GFAP) filaments, and quickly expanded astrocytic volume, predominantly visible at the somata. Conversely, H-OT released Gαi subunits and induced progressive volume expansion. Pretreatment of brain slices with U73122 (a Gq inhibitor) or SQ22536 (a Gs inhibitor) suppressed L-OT-induced excitation. Conversely, activation of adenylyl cyclase with forskolin reversed the inhibitory effect of H-OT, and inhibition of Gi with pertussis toxin blocked H-OT-induced inhibition. These findings imply that the dose-dependent effects of OT on OTN activity are mediated, at least partially, by different receptor-coupled G proteins and their subsequent modulation of astrocytic Kir4.1 currents, GFAP expression, and volume dynamics. This mechanism underlying the autoregulation of OTN activity provides an important reference for understanding the concentration-dependent neuromodulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.